Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OrbiMed Launches $600M Royalty Fund

This article was originally published in The Pink Sheet Daily

Executive Summary

The diversified investment firm will aim for low-risk investments that bring faster returns to inventors, research institutions and smaller drug developers.
Advertisement

Related Content

Capital Royalty To Offer Debt With New $1 Billion Fund
Financings Of The Fortnight: In The Aftermath Of Facebook IPO, Kythera Steps Up, TVAX And Cancer Genetics Back Off
For Biotech VCs, Anticipation And Adjustments In The Age Of Earn-Outs
Cowen Doubles Down On Royalties
Royalty Flush: Why Monetizing Tomorrow's Revenue Stream Today Could Catch on in a Big Way

Topics

Advertisement
UsernamePublicRestriction

Register

PS072719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel